Neurocrine Biosciences Inc.Equity-NMS: NBIX
Equity-NMS: NBIX
$147.43
+0.92
(13 Jul)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$147.43
Open
$147.43
Today’s high
$149.01
Today’s low
$146.99
52W low
$94.16
52W high
$149.01
1Y
55.01%
5Y
11.45%
PE
39.88
EPS (TTM)
3.60
Shares O/S
100.64M
Market cap
14.84B
Insights
NBIX has made a new 52 Wk high. 52 Wk high stocks tend to outperform in the near term.
NBIX price is above its 200 day moving average
NBIX PE is in the low end of its range over the past 2 years
NBIX is in the highest 10% returns in the past year. It is a high momentum stock. High momentum stocks tend to outperform in the near term.
In beta. Send feedback here.
Compare with other stock
Price
1D
PE
Market cap
About Neurocrine Biosciences Inc.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is engaged in discovering and developing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. Its diverse portfolio includes the United States Food and Drug Administration-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, endometriosis and uterine fibroids, as well as a robust pipeline, including multiple compounds in mid-to late-phase clinical development across its core therapeutic areas.

Its commercial products include INGREZZA, ALKINDI, EFMODY, Orilissa and Oriahnn. INGREZZA is marketed as DYSVAL (valbenazine) in Japan and REMLEAS (valbenazine) in other select Asian markets, where Mitsubishi Tanabe Pharma Corporation retains commercialization rights. ALKINDI is marketed as ALKINDI SPRINKLE (hydrocortisone) in the United States, where Eton Pharmaceuticals, Inc. retains commercialization rights. .


FAQs

Can I buy Neurocrine Biosciences Inc. shares in India?
How to buy Neurocrine Biosciences Inc. shares in India?
What is the share price of Neurocrine Biosciences Inc.?
What is the Market Capitalization of Neurocrine Biosciences Inc.?
What is the PE ratio of Neurocrine Biosciences Inc.?
Is Neurocrine Biosciences Inc. a good stock to buy?
In which sector / industry does Neurocrine Biosciences Inc. operate?